Provided by Tiger Fintech (Singapore) Pte. Ltd.

HBM HOLDINGS-B

8.270
-0.180-2.13%
Volume:6.89M
Turnover:56.55M
Market Cap:6.84B
PE:291.35
High:8.730
Open:8.600
Low:8.030
Close:8.450
Loading ...

HBM Holdings Limited (HKG:2142) Stock Catapults 78% Though Its Price And Business Still Lag The Industry

Simply Wall St.
·
21 Feb

HBM Holdings Sees Up to 22 Million Yuan Profit in 2024

MT Newswires Live
·
14 Feb

BRIEF-HBM Holdings Sees Profit Within Range Of RMB7.3 Mln To RMB22 Mln For Year

Reuters
·
14 Feb

Harbour Biomed Announces Business Progress and Update

THOMSON REUTERS
·
14 Feb

Press Release: Harbour BioMed Announces Business Progress and Update

Dow Jones
·
14 Feb

Hbm Holdings - Expected Result Due to Growth of Its Unique Business Model, Others

THOMSON REUTERS
·
14 Feb

Hbm Holdings Sees Profit Within Range of RMB7.3 Mln to RMB22 Mln for Year

THOMSON REUTERS
·
14 Feb

HBM Buys Back HK$10 Million Shares In One Day; Looks to Form Strategic Partnerships; Shares Rise 15%

MT Newswires Live
·
10 Feb

China Greenlights HBM's Investigational New Drug for COPD

MT Newswires Live
·
05 Feb

Stock Track | HBM Holdings-B Soars 5.66% on Regulatory Clearance for COPD Drug Candidate

Stock Track
·
05 Feb

BRIEF-HBM Holdings Says NMPA Ind Clearance For Hbm9378/Skb378

Reuters
·
05 Feb

Hbm Holdings - Nmpa Ind Clearance for Hbm9378/Skb378 in Treatment of Copd

THOMSON REUTERS
·
05 Feb

HBM's CEO Boosts Stakeholding

MT Newswires Live
·
03 Feb

BRIEF-HBM Says CEO & Chairman Purchased Total 400,000 Ordinary Shares Of Co

Reuters
·
28 Jan

Hbm - CEO & Chairman Purchased Total 400,000 Ordinary Shares of Co on 27 Jan for HK$3.5 per Share

THOMSON REUTERS
·
28 Jan

HBM, SKB Biopharma Sign License Agreement for Anti-Asthma, COPD Drug

MT Newswires Live
·
13 Jan

BRIEF-HBM Holdings Announces License Agreement With Windward Bio AG

Reuters
·
10 Jan

BRIEF-Windward Bio Launches With $200 Million Series A Financing

Reuters
·
10 Jan

Windward Bio Launches With $200 Million Series a Financing to Develop Phase 2-Ready, Long-Acting Anti-Tslp Antibody With Best-in-Class Potential in Asthma and Copd

THOMSON REUTERS
·
10 Jan

BRIEF-Harbour Biomed Signs License Agreement With Windward Bio For HBM9378

Reuters
·
10 Jan